On March 12, British Prime Minister Boris Johnson's claim that he wants to adopt a "group immunity" strategy to prevent and control the new coronavirus caused widespread controversy. In fact, the concept of "group immunity" is not biased from the perspective of infectious disease prevention and control, but its realization depends on the widespread vaccination. So in today's video, we will introduce the development principle and process of the vaccine, and see how it can fight with the human immune system "epidemic". Let's see that the vaccine is a quasi new one.
In the video review area of each issue of the "epidemic learning" series, the first participant who answers both questions correctly will get the mysterious gift bag!
Title of this issue:
1. What kind of vaccine is China's current phase I clinical trial vaccine? How is it prepared in the laboratory?
2. What are the main aspects of vaccine inspection in the marketing stage?
Video production: learning and production team from epidemic
Editor: Li Luyao
Reviewed by: Xin Hongliang, sun Xiangchao, Wu Yanming, Zhang Fuxian